Phio Pharmaceuticals Corp. — Director's Dealing 2024

Mar 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Phio Pharmaceuticals Corp. (PHIO)
CIK: 0001533040
Period of Report: 2024-03-01

Reporting Person: Kontulis Caitlin (Secretary & VP Finance & Admin)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-01	Common stock, $0.0001 par value	F	335	$0.958	Disposed	10643	Direct

Footnotes

F1: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting of restricted stock units. No shares were sold.

F2: Includes shares of common stock underlying unvested restricted stock units.